AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5152.00p Today's change: +0.57%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5152.00p 5 day change: +2.2%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5152.00p 6 month change: +21.07%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

The chief executive of pharmaceuticals giant AstraZeneca has written to staff to stifle rumours he is planning [...]

21 July 2017
Shares
3
Views
231

Shares in pharmaceutical giant AstraZeneca slid in morning trading after reports suggested its chief executive [...]

13 July 2017
Shares
10
Views
1,665

AstraZeneca today announced the sale of its migraine drug to Germany's Grunenthal. [...]

7 June 2017
Views
152

AstraZeneca today confirmed it priced a three-tranche bond offering totalling $2bn (£1.6bn) yesterday, which is [...]

6 June 2017
Shares
2
Views
289

FTSE 100 pharma giant AstraZeneca has sold the commercial rights to its Seloken heart medicines in Europe for [...]

22 May 2017
Shares
8
Views
206

Shares in AstraZeneca jumped nearly five per cent this morning, boosted by a successful trial of one of its [...]

12 May 2017
Shares
1
Views
677

One of Britain’s top captains of industry breathed a sigh of relief this week when he suggested to me that this [...]

28 April 2017
Shares
12
Views
570

The board of AstraZeneca was left with a bloody nose after nearly 40 per cent of voting shareholders opposed [...]

27 April 2017
Views
295

AstraZeneca said it will turn a corner in the second half of 2017 after facing plummeting revenues as drug patents [...]

27 April 2017
Views
260

Some of Britain’s biggest companies are set to face a fresh bout of shareholder rebellions over high levels [...]

23 April 2017
Shares
4
Views
995

Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]

19 March 2017
Views
471

Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]

17 March 2017
Views
301

Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]

15 March 2017
Shares
25
Views
902

AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]

20 February 2017
Views
238

AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]

2 February 2017
Views
571

Content tagged with "AstraZeneca"